Healthy volunteers help test new drug tablet design
NCT ID NCT07220551
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 19 times
Summary
This study tested two different tablet versions of a drug called UCB0022 in 14 healthy adults aged 18 to 55. The goal was to see how much of the drug gets into the blood and if one tablet works better than the other. Researchers also checked for any side effects. This is an early-stage study to gather information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UP0159 1
San Antonio, Texas, 78209, United States
Conditions
Explore the condition pages connected to this study.